Flavio Rocha/X
Jan 26, 2025, 15:22
Flavio Rocha: Congrats to the ACCELERATE investigators
Flavio Rocha, Hedinger Chair of Surgical Oncology and Physician-in-Chief OHSU Knight Cancer Institute, shared a post on X:
“Congrats to the ACCELERATE investigators for the first dedicated GBCA RCT to compare adjuvant chemotherapy vs chemoRT.
No diff in RFS between 6c GemOx or GemCis vs 3c chemo followed by 45 Gy of radiation with Cape (but closed early)
Consider enrolling patients in ECOG-ACRIN Cancer Research Group EA2197 in the US.”
More posts featuring Flavio Rocha.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 9, 2025, 14:01
May 9, 2025, 13:49
May 9, 2025, 13:37